Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells—Power of nutraceuticals
James A. McCubrey, Stephen L. Abrams, Kvin Lertpiriyapong, et al.
Advances in Biological Regulation (2017) Vol. 67, pp. 190-211
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Potential Adverse Effects of Resveratrol: A Literature Review
Abdullah Shaito, Anna Maria Posadino, Nadin Younes, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2084-2084
Open Access | Times Cited: 496
Resveratrol’ biotechnological applications: Enlightening its antimicrobial and antioxidant properties
Javad Sharifi‐Rad, Cristina Quispe, Alessandra Durazzo, et al.
Journal of Herbal Medicine (2022) Vol. 32, pp. 100550-100550
Closed Access | Times Cited: 70
Berberine as a potential autophagy modulator
Reza Mohammadinejad, Zahra Ahmadi, Shima Tavakol, et al.
Journal of Cellular Physiology (2019) Vol. 234, Iss. 9, pp. 14914-14926
Closed Access | Times Cited: 121
Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging
Przemysław Duda, J. Wisniewski, Tomasz Wójtowicz, et al.
Expert Opinion on Therapeutic Targets (2018) Vol. 22, Iss. 10, pp. 833-848
Closed Access | Times Cited: 109
Resveratrol Enhances Apoptotic and Oxidant Effects of Paclitaxel through TRPM2 Channel Activation in DBTRG Glioblastoma Cells
Yasin Öztürk, Caner Günaydın, Fatma Zehra YALÇIN, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-13
Open Access | Times Cited: 76
The science of resveratrol, formulation, pharmacokinetic barriers and its chemotherapeutic potential
Imogen Robertson, Tung Wai Hau, Farheen Sami, et al.
International Journal of Pharmaceutics (2022) Vol. 618, pp. 121605-121605
Closed Access | Times Cited: 44
Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments
Panchanan Maiti, Alexandra Plemmons, Gary Dunbar
PLoS ONE (2019) Vol. 14, Iss. 12, pp. e0225660-e0225660
Open Access | Times Cited: 59
Regulation of Cell Signaling Pathways by Berberine in Different Cancers: Searching for Missing Pieces of an Incomplete Jig-Saw Puzzle for an Effective Cancer Therapy
Ammad Ahmad Farooqı, Muhammad Zahid Qureshi, Sumbul Khalid, et al.
Cancers (2019) Vol. 11, Iss. 4, pp. 478-478
Open Access | Times Cited: 54
Metformin influences drug sensitivity in pancreatic cancer cells
Saverio Candido, Stephen L. Abrams, Linda S. Steelman, et al.
Advances in Biological Regulation (2018) Vol. 68, pp. 13-30
Closed Access | Times Cited: 48
Cancer therapy and treatments during COVID-19 era
Shaw M. Akula, Stephen L. Abrams, Linda S. Steelman, et al.
Advances in Biological Regulation (2020) Vol. 77, pp. 100739-100739
Open Access | Times Cited: 43
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells
Stephen L. Abrams, Matilde Y. Follo, Linda S. Steelman, et al.
Advances in Biological Regulation (2018) Vol. 71, pp. 172-182
Closed Access | Times Cited: 42
Unlocking the potential of Berberine: Advancing cancer therapy through chemosensitization and combination treatments
Anjana Sajeev, Bethsebie Sailo, Jyothsna Unnikrishnan, et al.
Cancer Letters (2024) Vol. 597, pp. 217019-217019
Closed Access | Times Cited: 4
From Nature to Nanotech: Unlocking Berberine’s Therapeutic Approaches
Shubham Chaudhari, Manoj Dalabehera, Rudra Narayan Subudhi, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106924-106924
Closed Access
Nuclear inositide signaling and cell cycle
Stefano Ratti, Giulia Ramazzotti, Irene Faenza, et al.
Advances in Biological Regulation (2017) Vol. 67, pp. 1-6
Closed Access | Times Cited: 35
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals
Stephen L. Abrams, Kvin Lertpiriyapong, Li V. Yang, et al.
Advances in Biological Regulation (2018) Vol. 69, pp. 16-34
Closed Access | Times Cited: 35
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells
Shaw M. Akula, Saverio Candido, Massimo Libra, et al.
Advances in Biological Regulation (2019) Vol. 73, pp. 100633-100633
Open Access | Times Cited: 35
Resveratrol Promotes Tumor Microvessel Growth via Endoglin and Extracellular Signal-Regulated Kinase Signaling Pathway and Enhances the Anticancer Efficacy of Gemcitabine against Lung Cancer
Sanhai Qin, Andy T. Y. Lau, Zhan‐Ling Liang, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 974-974
Open Access | Times Cited: 17
Protective effect of berberine against LPS-induced endothelial cell injury via the JNK signaling pathway and autophagic mechanisms
Junping Guo, Wei Chen, Beibei Bao, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 1324-1337
Open Access | Times Cited: 13
Effects of the MDM-2 inhibitor Nutlin-3a on PDAC cells containing and lacking WT-TP53 on sensitivity to chemotherapy, signal transduction inhibitors and nutraceuticals
Saverio Candido, Stephen L. Abrams, Linda S. Steelman, et al.
Advances in Biological Regulation (2019) Vol. 72, pp. 22-40
Closed Access | Times Cited: 11
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells
Shaw M. Akula, Saverio Candido, Stephen L. Abrams, et al.
Advances in Biological Regulation (2019) Vol. 75, pp. 100672-100672
Closed Access | Times Cited: 10
The Synthesis and Investigation of New Electroneutral Berberine Derivatives
Alexander D. Zagrebaev, Олег Н. Буров, Михаил Е. Клецкий, et al.
Chemistry of Heterocyclic Compounds (2022) Vol. 58, Iss. 1, pp. 45-57
Closed Access | Times Cited: 5
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53
Stephen L. Abrams, Shaw M. Akula, Alberto M. Martelli, et al.
Advances in Biological Regulation (2021) Vol. 79, pp. 100780-100780
Closed Access | Times Cited: 7
Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence and Perspectives
Marziyeh Salami, Raziyeh Salami, Mohammad Hossein Aarabi, et al.
Mini-Reviews in Medicinal Chemistry (2022) Vol. 23, Iss. 11, pp. 1167-1192
Closed Access | Times Cited: 3
Potential of Natural Products in the Treatment of Glioma: Focus on Molecular Mechanisms
Amirhossein Sheida, Marjan Farshadi, Amirhossein Mirzaei, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3157-3208
Closed Access
TP53 Gene Status can Promote Sensitivity and Resistance to Chemotherapeutic Drugs and Small Molecule Signal Transduction Inhibitors.
James A. McCubrey, Matilde Y. Follo, Stefano Ratti, et al.
Advances in Biological Regulation (2024), pp. 101073-101073
Closed Access
Page 1 - Next Page

Scroll to top